[PDF][PDF] Progress in Clinical Application of Carmustine
X Chen, F Wu, M Huang, Y Luo - Hans Journal of Medicinal …, 2018 - pdf.hanspub.org
… This article reviews the mechanism of action of carmustine and some clinical applications …
卡莫司汀与亚硒酸钠联用 前列腺癌(Castration resistant prostate cancer, CRPC)是最常见的癌症,…
卡莫司汀与亚硒酸钠联用 前列腺癌(Castration resistant prostate cancer, CRPC)是最常见的癌症,…
雄激素受体拮抗剂的构效关系, 虚拟筛选及活性评价研究
王灵燕 - 2018 - ir.lzu.edu.cn
… of new prostate cancer cases increased rapidly in China. … androgen receptor antagonists and
interaction mechanism were … foundation for discovery novel androgen receptor antagonists. …
interaction mechanism were … foundation for discovery novel androgen receptor antagonists. …
甾体类雄激素受体拮抗剂的构效关系及虚拟筛选研究
韩锐 - 2017 - ir.lzu.edu.cn
… as new PCa patients in 2012. Additionally researchers pointed out that prostate cancer is not
… Androgen receptor antagonists can be divided into two categories according to the structure…
… Androgen receptor antagonists can be divided into two categories according to the structure…
醣化ErbB4 影響雄性激素受體蛋白之機制探討
馬琮瑋 - 2010 - airitilibrary.com
… 雄性激素受體(Androgen receptor, AR)是已被廣為研究的分子.… cells into a malignant stage
or maintains prostate cancer cell … Here we provide a whole new mechanism through which …
or maintains prostate cancer cell … Here we provide a whole new mechanism through which …
4-[7-三氟甲基-5-(3, 4-二甲氧基苯基)-4, 5, 6, 7-四氢吡唑并[1, 5-a] 嘧啶-2-基] 苯甲酸的合成
张国泰 - 2015 - ir.lzu.edu.cn
… of anti-PCa drugs in the … of new anti-PCa drugs by deeply investigating the binding mode
between tetrahydro-pyrazolopyrimidines and androgen receptor and clarifying the mechanisms…
between tetrahydro-pyrazolopyrimidines and androgen receptor and clarifying the mechanisms…
抗雄激素药物治疗去势抵抗型前列腺癌的机制研究进展
王前奔, 吴大勇 - 中国肿瘤临床, 2015 - cjco.cn
… DNA motifs recognized by human androgen receptor in prostate cancer[J]. … Androgen
receptor functions in cas⁃ tration-resistant prostate cancer and mechanisms of resistance to new …
receptor functions in cas⁃ tration-resistant prostate cancer and mechanisms of resistance to new …
HER2 訊息途徑的活化調控雄性素受體功能與前列腺癌惡化關係之探討
PC Ho - 國立臺灣大學生化科學研究所學位論文, 2006 - airitilibrary.com
… Escaping from androgen ablation therapy makes prostate cancer intractable. The androgen
receptor (AR) remains active … This new pathway might provide possible targets for treating …
receptor (AR) remains active … This new pathway might provide possible targets for treating …
去势抵抗性前列腺癌的治疗进展
王晴, 杜君, 杨庆 - 中国肿瘤临床, 2016 - cjco.cn
… the underlying mechanisms of this cancer … new therapies for castration-resistant prostate
cancer have been proposed, such as androgen receptor antagonists, immunotherapeutic drugs, …
cancer have been proposed, such as androgen receptor antagonists, immunotherapeutic drugs, …
Molecular mechanism of spirit-quieting traditional Chinese medicine in the treatment of prostate cancer metastasis patients with depression: 宁神中药治疗前列腺癌 …
ZHU Liping, W Zhiqiang, LI Li, SU Zhiyong - 开元Medical-Research, 2022 - mrhk.cc
… acquired resistance. Metastatic castration-resistant prostate cancer is in critical need of new
… more agents which improved survival, including androgen receptor (AR)-targeted therapies (…
… more agents which improved survival, including androgen receptor (AR)-targeted therapies (…
[引用][C] 由動物實驗模式探討雄性素受體的輔助因子在雄性素不依賴性生長之機轉
張宏江 - 2004 - ntur.lib.ntu.edu.tw
… There are several evidences have been shown that during androgen deprivation, the
androgen receptor (AR) cofactors can enhance the transcription activity of AR to activate the AR …
androgen receptor (AR) cofactors can enhance the transcription activity of AR to activate the AR …